Related Experiment Video
Updated: Apr 20, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Lessons from Africa: developing a global human rights framework for tuberculosis control and prevention
Tracy Slagle1, Mehdi Ben Youssef2, Golda Calonge3
1The Earth Institute, Columbia University, New York, NY, USA. tracy.m.slagle@gmail.com.
Drug-resistant tuberculosis poses a global threat. An international framework, similar to tobacco control, is needed to balance patient rights and community safety, addressing policy gaps in many nations.
Area of Science:
- Public Health
- Infectious Disease Control
- Global Health Policy
Background:
- Tuberculosis (TB) is a contagious disease with increasing drug-resistant cases.
- Standard TB treatments are failing, necessitating stronger containment measures.
- Compulsory detention of non-adherent patients raises human rights concerns.
Purpose of the Study:
- To assess current national tuberculosis policies and identify gaps in addressing drug-resistant TB.
- To propose an international framework for tuberculosis control that balances public health with human rights.
Main Methods:
- Analysis of National Tuberculosis Programs' policies in African countries.
- Review of existing legal and public health frameworks for infectious disease control.
Main Results:
- Most surveyed African countries lack specific policies for drug-resistant TB or rely on general public health regulations.
- While some countries have policies for patient containment, enforcement is inadequate.
- Significant policy gaps exist in managing drug-resistant tuberculosis transmission.
Conclusions:
- An international framework, modeled on the Framework Convention on Tobacco Control, is essential for effective global TB control.
- This framework should define stakeholder rights and responsibilities, including patients, healthcare providers, and authorities.
- Establishing a WHO and Stop TB Partnership-led coordinating body can govern national obligations and ensure the global right to health.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

